What is the recommended dose of colistin (polymyxin E) for a patient with a urinary tract infection (UTI) and impaired renal function (eGFR of 56)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colistin Dosing for UTI with eGFR 56

For a patient with a UTI and eGFR of 56 mL/min, the recommended dose of colistin is 2.5-3.8 mg/kg/day divided into 2 doses per day. 1

Dosing Recommendations Based on Renal Function

  • For patients with mild renal impairment (eGFR 50-79 mL/min), the appropriate colistin dose is 2.5-3.8 mg/kg/day divided into 2 doses 1
  • A loading dose of 9 million international units (MIU) should be administered initially, regardless of renal function, to rapidly achieve therapeutic levels 2, 3
  • One million IU of colistin is equivalent to 80 mg of colistimethate sodium (CMS) 2
  • Colistin is administered as colistimethate sodium, which is an inactive prodrug 2

Administration Methods

  • Intravenous administration can be done via direct intermittent administration (slowly inject half the total daily dose over 3-5 minutes every 12 hours) 1
  • Alternatively, continuous infusion can be used after the initial loading dose 1
  • A 4-hour infusion is suggested to optimize pharmacokinetic/pharmacodynamic properties 2

Monitoring and Safety Considerations

  • Renal function should be closely monitored during colistin therapy as acute kidney injury is a significant factor related to clinical failure and mortality 4, 2
  • In the studied patient population, deterioration of renal function during colistin therapy was observed in 8% of patients 5
  • For UTIs specifically, colistin has shown high efficacy for treatment of complicated UTIs caused by multidrug-resistant organisms 6

Special Considerations for UTI Treatment

  • Aminoglycoside monotherapy is indicated for urinary tract infections, but colistin is an appropriate alternative for multidrug-resistant organisms 4
  • The suggested treatment duration for complicated urinary tract infection is 5-7 days 4
  • For UTIs specifically, lower doses may be effective due to higher urinary concentrations of colistin compared to plasma levels 6

Common Pitfalls and Caveats

  • Colistin doses often vary greatly among patients, and in patients with renal impairment, dosing is commonly not in accordance with guidelines 7
  • Avoid underdosing in the initial phase of treatment - the loading dose is critical due to colistin's relatively long half-life 2, 3
  • Balance potential antibacterial benefit against risk of nephrotoxicity by monitoring renal function regularly 4
  • Colistin nephrotoxicity rarely requires renal replacement therapy 7

Remember that while the recommended dose is 2.5-3.8 mg/kg/day for a patient with eGFR 56 mL/min, clinical response and renal function should be monitored throughout the treatment course.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.